More Intense Neoadjuvant ECX Regimen Fails for Esophageal Cancer More Intense Neoadjuvant ECX Regimen Fails for Esophageal Cancer

Dr Kerr reports on a large, well-designed trial with disappointing results.Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news